ALEXANDRIA, Va., Dec. 16 -- United States Patent no. 12,496,327, issued on Dec. 16, was assigned to President and Fellows of Harvard College (Cambridge, Mass.).
"Methods and compositions for restoring STMN2 levels" was invented by Kevin C. Eggan (Boston), Joseph Robert Klim (Boston), Francesco Limone (Cambridge, Mass.), Irune Guerra San Juan (Cambridge, Mass.) and Luis Williams (Cambridge, Mass.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to compositions and methods for treating a disease or condition associated with a TDP-pathology or a decline in TDP-43 functionality in neuronal cells in a subject, and for identifying candidate agents to restore expression of a normal full-length ...